Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Biolinerx Ltd (NQ: BLRX)
1.710 USD  -0.230 (-11.86%)
Streaming Delayed Price  /  Updated: 10:50 AM EDT, Jun 1, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 2,630,670
Open 1.660
Bid (Size) 1.710 (10)
Ask (Size) 1.720 (12)
Prev. Close 1.940
Today's Range 1.630 - 1.720
52wk Range 0.2950 - 4.750
Shares Outstanding 108,032,164
Dividend Yield N/A
Performance
YTD
-26.92%
-26.92%
1 Month
+3.64%
+3.64%
3 Month
-10.94%
-10.94%
6 Month
-36.67%
-36.67%
1 Year
+395.65%
+395.65%
Top News
More News
BioLineRx Announces $4.39 Million Registered Direct Offering
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today announced that it has entered into definitive agreements with several... Read More
from PR Newswire
BioLineRx Announces Publication of Data from Ongoing COMBAT/KEYNOTE-202 Clinical Trial in Nature Medicine
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical Company focused on oncology, today announced that a paper, entitled 'BL-8040, a CXCR4 Antagonist, in Combination with... Read More
from PR Newswire
More News
Read More
BioLineRx Announces $9.0 Million Registered Direct Offering
from PR Newswire
BioLineRx Reports First Quarter 2020 Financial Results and Provides Corporate Update
from PR Newswire
BioLineRx to Report First Quarter 2020 Results on May 20, 2020
from PR Newswire
BioLineRx Reports Year-End 2019 Financial Results and Provides Corporate Update
from PR Newswire
BioLineRx to Report Annual 2019 Results on March 12, 2020
from PR Newswire
BioLineRx Announces Notice of Allowance from USPTO for Patent Covering Motixafortide (BL-8040) in Combination With Anti-PD-1 for the Treatment of Any Type of Cancer
from PR Newswire
BioLineRx Completes Recruitment in Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer
from PR Newswire
Mid-Afternoon Market Update: Crude Oil Up 2%; argenx Shares Spike Higher
category Market News , Penny Stocks , Markets , and 17 more.
from Benzinga
Mid-Day Market Update: Dow Jumps Over 600 Points; BioLineRx Shares Plunge
category Mid/Day Market Update , FLY , MTC , and 17 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.